![{[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]amino}acetic acid](https://img.chemicalbook.in/ProductImageIndia/2021-12-25/125.png)
![{[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]amino}acetic acid](https://img.chemicalbook.in/ProductImageIndia/2021-12-25/125.png)
![{[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]amino}acetic acid](https://img.chemicalbook.in/ProductImageIndia/2021-12-25/126.jpg)
dabigartan intermediate 872728-82-0
Price | INR17000.00 |
- Min. Order:1g
- Time:2022-03-04
Product Details
- Product Name{[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]amino}acetic acid
- Other NamesN-[4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]-;2-((4-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)amino)acetic acid
- CAS No.872728-82-0
- EINECS No.460-450-2
- MFC10H9N3O4
- MW235.2
- density 1.57
- storage temp. 2-8°C
N-[4-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)PHENYL]GLYCINE is dabigartan intermediate.
Intermediates
# | THERAPEUTIC CATEGORY & PRODUCTS | CAS NO | STATUS | |
---|---|---|---|---|
Atazanavir | ||||
1. | (AZS-3)3S,8S,9S,12S)-3,12-Bis(1,1-dimethyl ethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetra decanedioic acid dimethyl ester | 1292296-09-3 | Commercial | |
Azilsartan | ||||
2. | Methyl 1-[(2’-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1h-benzimidazole-7-carboxylate | 139481-44-0 | Under Development | |
Methyl 2-ethoxybenzimidazole-7-carboxylate,methyl 2-ethoxybenzimidazole-7-carboxylate | 150058-27-8 | |||
Biperiden Base | ||||
3. | Alpha-5-Norbornene-2-yl-alphaphentl-1-piperidinepropanol | 514-65-8 | Commercial | |
4. | Cyclo propyl Amine (CPA) | 765-30-0 | Commercial | |
Dabigartan | ||||
5. | {[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]amino}acetic acid | 872728-82-0 | Commercial | |
Company Profile Introduction
SGMR Pharmaceuticals Pvt Ltd. is a renowned Loan License manufacturer of API’s and Intermediates. We are headquartered in Hyderabad, Telangana, India. And also we have a marketing branch office in Scotland (UK). We specialize in the product manufacturing and export of Bulk drugs Products and Intermediates. Our customers and buyers include reputed pharmaceutical companies of the US, Europe, Middle-East, Africa, Latin America, and the CIS region, Asian Countries.
Starting from a single product line, SGMR Pharmaceuticals Pvt Ltd has emerged as a diversified multi-product company, with interests in the production of API Products and API Intermediates. We bring together more than 10 years of experience in the manufacturing of API Products and Intermediates.
SGMR Pharmaceuticals Pvt Ltd is managed by a team of business managers who have proven experience in running the organization professionally. Our team includes young professionals in-charge of Production, Marketing, Finance, Process development, R&D, Quality Control, and Quality Assurance.
Our business, the methodology aims to realize to completion futuristic synergy of backward integration. We ensure that at no point of time our production commitments to our clients in supplying API products and Extended Products will be met 100%.
Vision :
Our vision is to become an innovative and reliable pharmaceutical company. SGMR Pharmaceuticals Pvt Ltd wants to excel in the manufacturing of the highest quality products with ethical standards and obligations to do right and fair and to become the most preferred supply partner to our customers and achieve sustained growth, through consistent delivery of innovative quality of products.
We strongly believe SGMR Pharmaceuticals Pvt Ltd can, and should, meet all the existing regulations for APIs and Intermediates.
Our imaginative and prescient is to provide first-class products and services to our customers. To usually exceed purchaser expectations resu
SGMR Pharmaceuticals Pvt Ltd is managed by a team of business managers who have proven experience in running the organization professionally. Our team includes young professionals in-charge of Production, Marketing, Finance, Process development, R&D, Quality Control, and Quality Assurance.
Our business, the methodology aims to realize to completion futuristic synergy of backward integration. We ensure that at no point of time our production commitments to our clients in supplying API products and Extended Products will be met 100%.
Vision :
Our vision is to become an innovative and reliable pharmaceutical company. SGMR Pharmaceuticals Pvt Ltd wants to excel in the manufacturing of the highest quality products with ethical standards and obligations to do right and fair and to become the most preferred supply partner to our customers and achieve sustained growth, through consistent delivery of innovative quality of products.
We strongly believe SGMR Pharmaceuticals Pvt Ltd can, and should, meet all the existing regulations for APIs and Intermediates.
Our imaginative and prescient is to provide first-class products and services to our customers. To usually exceed purchaser expectations resu
Recommended supplier
-
VIP2年
- Vignasai Laboratories Pvt Ltd
- 872728-82-0 Glycine, N-(4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl) 98%
- Inquiry
- 2023-06-03
-
VIP2年
- Vignasai Laboratories Pvt Ltd
- 872728-82-0 98%
- Inquiry
- 2023-06-03
-
VIP1年
- Sri Vyjayanthi Labs Pvt Ltd
- (4S)-3-[5-(4-fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone 189028-93-1 98%
- Inquiry
- 2024-03-18
- Address:
INQUIRY